Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Sales | 18,849,000 | 17,841,000 | 16,663,000 | 18,298,000 | 18,445,000 |
Cost of Goods | 4,469,000 | 4,520,000 | 4,490,000 | 5,491,000 | 15,888,000 |
Gross Profit | 14,380,000 | 13,321,000 | 12,173,000 | 12,807,000 | 2,557,000 |
Operating Expenses | 10,469,000 | 9,558,000 | 8,908,000 | 9,586,000 | 0 |
Operating Income | 3,911,000 | 3,763,000 | 3,265,000 | 3,221,000 | 2,557,000 |
Interest Expense | 0 | 0 | 105,000 | 135,000 | 1,013,000 |
Other Income | 291,000 | 274,000 | 917,000 | 761,000 | 419,000 |
Pre-tax Income | 4,202,000 | 4,037,000 | 4,077,000 | 3,847,000 | 1,963,000 |
Income Tax | 1,143,000 | 1,177,000 | 1,099,000 | 1,299,000 | 815,000 |
Net Income Continuous | 3,036,000 | 2,840,000 | 3,107,640 | 2,538,000 | 2,508,000 |
Net Income | $3,036,000 | $2,860,000 | $2,967,000 | $2,538,000 | $1,143,000 |
EPS Basic Total Ops | 0.89 | 0.82 | 0.85 | 0.72 | 0.32 |
EPS Basic Continuous Ops | 0.89 | 0.82 | 0.88 | 0.72 | 0.71 |
EPS Diluted Total Ops | 0.89 | 0.82 | 0.85 | 0.72 | 0.32 |
EPS Diluted Continuous Ops | 0.89 | 0.82 | 0.88 | 0.72 | 0.70 |
EBITDA(a) | $3,911,000 | $3,763,000 | $4,125,000 | $4,209,000 | $2,557,000 |